AKCEA THERAPEUTICS, INC. September 19, 2019Akcea Therapeutics, Inc. • September 23rd, 2019 • Pharmaceutical preparations • Massachusetts
We are pleased to inform you that the Compensation Committee of the Board of Directors of Akcea Therapeutics, Inc. (the “Company”) has approved severance and vesting acceleration terms for you, which are described in this letter agreement (the “Agreement”). This Agreement will supersede and replace any prior agreements providing for severance benefits by and between you and the Company.
